Mammographic screening programmes in Europe: organization, coverage and participation

被引:114
|
作者
Giordano, Livia [1 ]
von Karsa, Lawrence [2 ]
Tomatis, Mariano [1 ]
Majek, Ondrej [3 ]
de Wolf, Chris [4 ,5 ]
Lancucki, Lesz [6 ]
Hofvind, Solveig [7 ]
Nystrom, Lennarth [8 ]
Segnan, Nereo [9 ]
Ponti, Antonio [1 ]
机构
[1] AOU S Giovanni Battista, CPO Piemonte, Epidemiol Unit, I-10123 Turin, Italy
[2] Agcy Res Canc, Sect Early Detect & Prevent, Qual Assurance Grp, European Canc Network ECN Screening & Prevent, Lyon, France
[3] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic
[4] Breast Canc Screening Program, Fribourg, Switzerland
[5] Swiss Federat Breast Canc Screening, Bern, Switzerland
[6] NHS Canc Screening Programmes, Sheffield, S Yorkshire, England
[7] Canc Registry Norway, Dept Res, Oslo, Norway
[8] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden
[9] AOU S Giovanni Battista, CPO Piemonte, Canc Epidemiol Unit, Dept Canc Screening, I-10123 Turin, Italy
关键词
QUALITY-ASSURANCE; PERFORMANCE INDICATORS; BREAST; GUIDELINES; EDITION;
D O I
10.1258/jms.2012.012085
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives To summarize participation and coverage rates in population mammographic screening programmes for breast cancer in Europe. Methods We used the European Network for Information on Cancer (EUNICE), a web-based data warehouse (EUNICE Breast Cancer Screening Monitoring, EBCSM) for breast cancer screening, to obtain information on programme characteristics, coverage and participation from its initial application in 10 national and 16 regional programmes in 18 European countries. Results The total population targeted by the screening programme services covered in the report comprised 26.9 million women predominantly aged 50-69. Most of the collected data relates to 2005, 2006 and/or 2007. The average participation rate across all programmes was 53.4% (range 19.4-88.9% of personally invited); or 66.4% excluding Poland, a large programme that initiated personal invitations in 2007. Thirteen of the 26 programmes achieved the European Union benchmark of acceptable participation (>70%), nine achieved the desirable level (>75%). Despite considerable invitation coverage across all programmes (79.3%, range 50.9-115.2%) only 48.2% (range 28.4-92.1%) of the target population were actually screened. The overall invitation and examination coverage excluding Poland was 70.9% and 50.3%, respectively. Conclusions The results demonstrate the feasibility of European-wide screening monitoring using the EBCSM data warehouse, although further efforts to refine the system and to harmonize standards and data collection practices will be required, to fully integrate all European countries. The more than threefold difference in the examination coverage should be taken into account in the evaluation of service screening programmes.
引用
收藏
页码:72 / 82
页数:11
相关论文
共 50 条
  • [41] MAMMOGRAPHIC SCREENING
    KOPANS, DB
    LANCET, 1993, 342 (8864): : 183 - 183
  • [42] Lack of social support, gender and colorectal cancer screening participation across Europe: How do screening programmes mitigate the effect of social support for men and women?
    Jolidon, Vladimir
    De Prez, Vincent
    Bracke, Piet
    Cullati, Stephane
    Burton-Jeangros, Claudine
    SOCIOLOGY OF HEALTH & ILLNESS, 2024, 46 (06) : 1212 - 1237
  • [43] Predictive factors for non-participation or partial participation in breast, cervical and colorectal cancer screening programmes
    Dawidowicz, Sebastien
    Le Breton, Julien
    Moscova, Laura
    Renard, Vincent
    Bercier, Sandrine
    Brixi, Zahida
    Audureau, Etienne
    Clerc, Pascal
    Bastuji-Garin, Sylvie
    Ferrat, Emilie
    FAMILY PRACTICE, 2020, 37 (01) : 15 - 24
  • [44] Predictive factors for non-participation or partial participation in breast, cervical and colorectal cancer screening programmes
    Berkhout, Christophe
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2020, (163): : 202 - 203
  • [45] The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies
    Broeders, Mireille
    Moss, Sue
    Nystrom, Lennarth
    Njor, Sisse
    Jonsson, Hakan
    Poop, Ellen
    Massat, Nathalie
    Duffy, Stephen
    Lynge, Elsebeth
    Paci, Eugenio
    JOURNAL OF MEDICAL SCREENING, 2012, 19 : 14 - 25
  • [46] The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies
    Moss, S. M.
    Nystrom, L.
    Jonsson, H.
    Paci, E.
    Lynge, E.
    Njor, S.
    Broeders, M.
    JOURNAL OF MEDICAL SCREENING, 2012, 19 : 26 - 32
  • [47] The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe
    Barben, Jurg
    Castellani, Carlo
    Dankert-Roelse, Jeannette
    Gartner, Silvia
    Kashirskaya, Nataliya
    Linnane, Barry
    Mayell, Sarah
    Munck, Anne
    Sands, Dorota
    Sommerburg, Olaf
    Pybus, Simon
    Winters, Victoria
    Southern, Kevin
    SWISS MEDICAL WEEKLY, 2017, 147 : 39S - 40S
  • [48] The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe
    Barben, Jurg
    Castellani, Carlo
    Dankert-Roelse, Jeannette
    Gartner, Silvia
    Kashirskaya, Nataliya
    Linnane, Barry
    Mayell, Sarah
    Munck, Anne
    Sands, Dorota
    Sommerburg, Olaf
    Pybus, Simon
    Winters, Victoria
    Southern, Kevin W.
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (02) : 207 - 213
  • [49] Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia
    Aceijas, Carmen
    Hickman, Matthew
    Donoghoe, Martin C.
    Burrows, Dave
    Stuikyte, Raminta
    ADDICTION, 2007, 102 (08) : 1244 - 1250
  • [50] Computer modelling of the Swedish two county trial of mammographic screening and trade offs between participation and screening interval
    Fett, MJ
    JOURNAL OF MEDICAL SCREENING, 2001, 8 (01) : 39 - 45